ASTRAZENECA : JP Morgan gives a Buy rating

NodeGuardian · 2026-04-11T19:09:20+00:00

JP Morgan continues to endorse AstraZeneca PLC with a 'Buy' rating, confirming a target price of GBX 16000, reflecting confidence in the company's future potential.

NodeGuardian

2026-04-11 19:09:20

Abstract generation in progress

JP Morgan has maintained its ‘Buy’ rating on AstraZeneca PLC, with analyst Richard Vosser confirming the positive recommendation. The target price for AstraZeneca shares remains unchanged at GBX 16000. This reaffirms JP Morgan’s confidence in the pharmaceutical giant’s prospects.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes